493 related articles for article (PubMed ID: 17234809)
21. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.
Menéndez-Arias L
Rev Med Virol; 2011 Jan; 21(1):3-17. PubMed ID: 21294212
[TBL] [Abstract][Full Text] [Related]
22. Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells.
Stürzel CM; Palesch D; Khalid M; Wissing S; Fischer N; Münch J
PLoS One; 2013; 8(9):e74427. PubMed ID: 24058563
[TBL] [Abstract][Full Text] [Related]
23. XMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?
Stieler K; Schumacher U; Horst AK; Fischer N
PLoS One; 2012; 7(7):e42321. PubMed ID: 22848758
[TBL] [Abstract][Full Text] [Related]
24. Zinc-finger antiviral protein inhibits XMRV infection.
Wang X; Tu F; Zhu Y; Gao G
PLoS One; 2012; 7(6):e39159. PubMed ID: 22720057
[TBL] [Abstract][Full Text] [Related]
25. The prostate cancer-associated human retrovirus XMRV lacks direct transforming activity but can induce low rates of transformation in cultured cells.
Metzger MJ; Holguin CJ; Mendoza R; Miller AD
J Virol; 2010 Feb; 84(4):1874-80. PubMed ID: 20007266
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors.
Qiu X; Swanson P; Tang N; Leckie GW; Devare SG; Schochetman G; Hackett J
Transfusion; 2012 Feb; 52(2):307-16. PubMed ID: 22023235
[TBL] [Abstract][Full Text] [Related]
27. Fidelity of target site duplication and sequence preference during integration of xenotropic murine leukemia virus-related virus.
Kim S; Rusmevichientong A; Dong B; Remenyi R; Silverman RH; Chow SA
PLoS One; 2010 Apr; 5(4):e10255. PubMed ID: 20421928
[TBL] [Abstract][Full Text] [Related]
28. Absence of xenotropic murine leukemia virus-related virus in blood donors in China.
Mi Z; Lu Y; Zhang S; An X; Wang X; Chen B; Wang Q; Tong Y
Transfusion; 2012 Feb; 52(2):326-31. PubMed ID: 21854397
[TBL] [Abstract][Full Text] [Related]
29. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection.
Danziger O; Shai B; Sabo Y; Bacharach E; Ehrlich M
Oncotarget; 2016 Aug; 7(32):52115-52134. PubMed ID: 27366948
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients.
Verhaegh GW; de Jong AS; Smit FP; Jannink SA; Melchers WJ; Schalken JA
Prostate; 2011 Mar; 71(4):415-20. PubMed ID: 20878949
[TBL] [Abstract][Full Text] [Related]
31. Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer.
Babaei F; Ahmadi A; Rezaei F; Jalilvand S; Ghavami N; Mahmoudi M; Abiri R; Kondori N; Nategh R; Mokhtari Azad T
Iran Red Crescent Med J; 2015 Dec; 17(12):e19439. PubMed ID: 26744630
[TBL] [Abstract][Full Text] [Related]
32. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV.
Stieler K; Schulz C; Lavanya M; Aepfelbacher M; Stocking C; Fischer N
Virology; 2010 Mar; 399(1):23-30. PubMed ID: 20110097
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of xenotropic murine leukemia virus and its R426Q polymorphism in patients with prostate cancer in Kerman, southeast of Iran.
Reza MA; Fahimeh G; Reza MH
Asian Pac J Cancer Prev; 2012; 13(8):3669-73. PubMed ID: 23098452
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
[TBL] [Abstract][Full Text] [Related]
35. Androgen stimulates transcription and replication of xenotropic murine leukemia virus-related virus.
Dong B; Silverman RH
J Virol; 2010 Feb; 84(3):1648-51. PubMed ID: 19906923
[TBL] [Abstract][Full Text] [Related]
36. XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH.
Arnold RS; Makarova NV; Osunkoya AO; Suppiah S; Scott TA; Johnson NA; Bhosle SM; Liotta D; Hunter E; Marshall FF; Ly H; Molinaro RJ; Blackwell JL; Petros JA
Urology; 2010 Apr; 75(4):755-61. PubMed ID: 20371060
[TBL] [Abstract][Full Text] [Related]
37. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
38. Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2',5'-oligoadenylates.
Xiang Y; Wang Z; Murakami J; Plummer S; Klein EA; Carpten JD; Trent JM; Isaacs WB; Casey G; Silverman RH
Cancer Res; 2003 Oct; 63(20):6795-801. PubMed ID: 14583476
[TBL] [Abstract][Full Text] [Related]
39. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
40. Ductal variant of prostate adenocarcinoma harbor Xenotropic murine leukemia virus related virus (XMRV) infection: a novel finding in subtype of prostate cancer.
Baig FA; Mirza T; Hamid A; Syed S; Jamal Q
Turk J Urol; 2017 Sep; 43(3):268-272. PubMed ID: 28861296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
